Option chain shows key data for NexImmune's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NexImmune.

NexImmune (OTC:NEXI) Stock, Option Chain

NexImmune

NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AEYE

AISP

ANTE

ARHS

AVGR

BENF

BREA

CDMO

CELZ

CERO

CIEN

CMPO

CRBP

DAVE

EHAB

ETWO

GROM

HDSN

HNST

MNMD

NEXI

NWGL

OCEA

OSPN

STVN

SWIN

TPVG

VKTX

VSCO

YEXT

YGMZ

Shares of  HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

ADVM

BETS

BTOG

CAMP

CCTG

CHEA

Envoy Medical, Inc. - Class A Common Stock

COCH

COIN

Core Scientific, Inc. - Class A Common Stock

CORZ

CTLT

EVBG

EXPR

FDMT

GRDI

GRRR

Intelligent Bio Solutions Inc. - Common Stock

INBS

LXEH

MIRA

Morgan Stanley Capital Protected Notes for S&P 500 Index

NOVA

NSTG

PEGY

PLRX

PLUG

PRSO

QLYS

RVSN

SGML

SPWR

TRUG

TSLA

WRAP

YTEN

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

ATRA

BCEL

BIOR

CANO

CVKD

DCFC

MEGL

TWOU

WORX

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.

4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability &amp; clinical activity in wet AMD.

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Comments

NexImmune

NexImmune (NEXI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga